Lin‐Hai Yan

438 total citations
23 papers, 310 citations indexed

About

Lin‐Hai Yan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lin‐Hai Yan has authored 23 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Lin‐Hai Yan's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Digestive system and related health (4 papers). Lin‐Hai Yan is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Digestive system and related health (4 papers). Lin‐Hai Yan collaborates with scholars based in China, United Kingdom and United States. Lin‐Hai Yan's co-authors include Yubo Xie, Weiyuan Wei, Wenlong Cao, Qiang Xiao, Lu Lu, Ying Li, Li Li, Jiansi Chen, Xianwei Mo and Xiaoshi Zhang and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Frontiers in Immunology and World Journal of Gastroenterology.

In The Last Decade

Lin‐Hai Yan

22 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin‐Hai Yan China	11	218	146	80	38	32	23	310
Yizhi Xiao China	9	202 0.9×	99 0.7×	69 0.9×	45 1.2×	21 0.7×	16	264
Runyi Ye China	12	192 0.9×	142 1.0×	66 0.8×	45 1.2×	27 0.8×	15	306
Boan Zheng China	12	252 1.2×	154 1.1×	88 1.1×	47 1.2×	43 1.3×	21	364
Chuanchao He China	12	295 1.4×	166 1.1×	71 0.9×	50 1.3×	37 1.2×	21	411
Xinwei Yun China	11	345 1.6×	147 1.0×	99 1.2×	36 0.9×	56 1.8×	21	509
Shan Liu China	12	252 1.2×	239 1.6×	66 0.8×	49 1.3×	28 0.9×	34	376
Feiye Liu China	9	213 1.0×	148 1.0×	44 0.6×	23 0.6×	18 0.6×	13	294
Kaori Yuuki Japan	7	330 1.5×	118 0.8×	68 0.8×	49 1.3×	28 0.9×	10	381
Anlong Zhu China	9	253 1.2×	177 1.2×	72 0.9×	17 0.4×	27 0.8×	21	344
Yaozhen Pan China	7	176 0.8×	92 0.6×	91 1.1×	44 1.2×	26 0.8×	22	284

Countries citing papers authored by Lin‐Hai Yan

Since Specialization

Citations

This map shows the geographic impact of Lin‐Hai Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin‐Hai Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin‐Hai Yan more than expected).

Fields of papers citing papers by Lin‐Hai Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin‐Hai Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin‐Hai Yan. The network helps show where Lin‐Hai Yan may publish in the future.

Co-authorship network of co-authors of Lin‐Hai Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Lin‐Hai Yan. A scholar is included among the top collaborators of Lin‐Hai Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin‐Hai Yan. Lin‐Hai Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wei, Xiaoxia, Wene Wei, Bo Li, et al.. (2025). Trifluridine/tipiracil induces ferroptosis by targeting p53 via the p53-SLC7A11 axis in colorectal cancer 3D organoids. Cell Death and Disease. 16(1). 255–255. 3 indexed citations

Yan, Lin‐Hai, et al.. (2023). Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer. Frontiers in Immunology. 14. 1179699–1179699. 10 indexed citations

Yan, Lin‐Hai, et al.. (2021). Anlotinib suppresses metastasis and multidrug resistance via dual blockade of MET/ABCB1 in colorectal carcinoma cells. Journal of Cancer. 12(7). 2092–2104. 6 indexed citations

Yan, Lin‐Hai, et al.. (2021). OX40 as a novel target for the reversal of immune escape in colorectal cancer.. American Journal of Translational Research. 13(3). 923–934. 9 indexed citations

Wei, Weiyuan, et al.. (2019). <p>MiR-1284 suppresses gastric cancer progression by targeting EIF4A1</p>. OncoTargets and Therapy. Volume 12. 3965–3976. 20 indexed citations

Zhang, Di, et al.. (2019). Targeting snoRNAs as an emerging method of therapeutic development for cancer.. PubMed. 9(8). 1504–1516. 22 indexed citations

Yan, Lin‐Hai, Chunjun Li, Jia Chen, et al.. (2018). Prolonging Gastrointestinal-Stromal-Tumor-free life, an optimal suggestion of imatinib intervention ahead of operation. Journal of Cancer. 9(21). 3850–3857. 2 indexed citations

Wei, Weiyuan, Wenlong Cao, Lin‐Hai Yan, et al.. (2018). Regulation of cell proliferation and metastasis by microRNA-593-5p in human gastric cancer. OncoTargets and Therapy. Volume 11. 7429–7440. 9 indexed citations

Chen, Jia, Guanqiao Jin, Lin‐Hai Yan, & Danke Su. (2017). Association between integrin αvβ3 expression and malignancy lymph node metastasis: A meta-analysis. Biomedical Research-tokyo. 28(7). 2946–2951. 1 indexed citations

10.

Li, Li, et al.. (2017). Central Role of CEMIP in Tumorigenesis and Its Potential as Therapeutic Target. Journal of Cancer. 8(12). 2238–2246. 45 indexed citations

11.

Yan, Lin‐Hai, Li Li, Jia Chen, et al.. (2016). E2F-1 promotes DAPK2-induced anti-tumor immunity of gastric cancer cells by targeting miR-34a. Tumor Biology. 37(12). 15925–15936. 15 indexed citations

12.

Yan, Lin‐Hai, Li-Li Li-Li, Jia Chen, et al.. (2016). miR-135a promotes gastric cancer progression and resistance to oxaliplatin. Oncotarget. 7(43). 70699–70714. 28 indexed citations

13.

Wei, Weiyuan, Lei Li, Xiaotong Wang, et al.. (2015). Overexpression of caudal type homeobox transcription factor 2 inhibits the growth of the MGC-803 human gastric cancer cell line in vivo. Molecular Medicine Reports. 12(1). 905–912. 1 indexed citations

14.

Chen, Jia, Qi Wang, Fuqiang Yin, et al.. (2015). MTRR silencing inhibits growth and cisplatin resistance of ovarian carcinoma via inducing apoptosis and reducing autophagy.. PubMed. 7(9). 1510–27. 20 indexed citations

15.

Yan, Lin‐Hai. (2014). New insights into the functions and localization of the homeotic geneCDX2in gastric cancer. World Journal of Gastroenterology. 20(14). 3960–3960. 9 indexed citations

16.

Yan, Lin‐Hai, Weiyuan Wei, Wenlong Cao, et al.. (2014). Overexpression of E2F1 in human gastric carcinoma is involved in anti-cancer drug resistance. BMC Cancer. 14(1). 904–904. 40 indexed citations

17.

Yan, Lin‐Hai. (2013). Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation. World Journal of Gastroenterology. 19(26). 4155–4155. 14 indexed citations

18.

Yan, Lin‐Hai, Xiao‐Tong Wang, Jie Yang, et al.. (2013). Reversal of Multidrug Resistance in Gastric Cancer Cells by E2F‐1 Downregulation In Vitro and In Vivo. Journal of Cellular Biochemistry. 115(1). 34–41. 25 indexed citations

19.

Khurana, Taruna, et al.. (2012). Radial Immunodiffusion (RID) to Sandwich ELISA for the Quantitation of Fel d 1 and Amb a 1 in Cat and Short Ragweed Pollen Allergenic Extracts. Journal of Allergy and Clinical Immunology. 129(2). AB88–AB88.

20.

Yan, Lin‐Hai, Lei Li, Yubo Xie, Qiang Xiao, & Changqing Wang. (2009). Effects of E2F-1 overexpression on apoptosis of gastric cancer cells and expressions of apoptosis-related genes. Chinese Journal of Cancer. 28(11). 1176–1180. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact